Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
29.00
+3.81 (15.13%)
At close: Feb 6, 2026, 4:00 PM EST
28.48
-0.52 (-1.79%)
After-hours: Feb 6, 2026, 7:38 PM EST
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $401.78 million as of February 6, 2026. Its market cap has increased by 135.12% in one year.
Market Cap
401.78M
Enterprise Value
397.97M
1-Year Change
135.12%
Ranking
Category
Stock Price
$29.00
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $401.78M, an increase of 484.94%. That is a compound annual growth rate of 38.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 401.78M | 38.03% |
| Dec 31, 2025 | 291.08M | 97.19% |
| Dec 31, 2024 | 147.61M | 9.21% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adlai Nortye | 374.17M |
| Bicycle Therapeutics | 368.34M |
| Aclaris Therapeutics | 367.29M |
| Allogene Therapeutics | 366.31M |
| Entrada Therapeutics | 360.41M |
| Autolus Therapeutics | 351.31M |
| Protara Therapeutics | 348.32M |
| Puma Biotechnology | 342.16M |